Horizon Therapeutics (HZNP) PT Raised to $125 at Piper Sandler
Tweet Send to a Friend
Piper Sandler analyst David Amsellem raised the price target on Horizon Therapeutics (NASDAQ: HZNP) to $125.00 (from $123.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
